Loading...
Reduction of endothelial dysfunction following VEGF gene therapy
BACKGROUND/OBJECTIVES: Vascular endothelial growth factor (VEGF) is a potent angiogenic factor. VEGF gene therapy improves perfusion of ischaemic myocardium in experimental models and possibly in patients with end-stage coronary artery disease. In addition to its proliferative and migratory effect o...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2005
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2497290/ https://ncbi.nlm.nih.gov/pubmed/25696473 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|